Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives

January 31, 2024

https://www.globenewswire.com/news-release/2024/01/31/2821047/0/en/Windtree-Therapeutics-Announces-Engagement-of-Strategic-Advisor-to-Support-Assessment-of-Strategic-Alternatives.html

WARRINGTON, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for critical cardiovascular disorders, today announced that it has engaged Ladenburg Thalmann & Co. Inc. (“Ladenburg”) to evaluate strategic alternatives for the Company with the goal of maximizing stockholder value.

Read more at globenewswire.com

Related news for (WINT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.